High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis
This study illustrates that even without overt drug prescription inequity, access to medication is not evenly distributed and depends on economic strength and regional medical care density.
Authors
- Ralph Brinks (ORCID: https://orcid.org/0000-0003-0961-6592)
- Sara Samadzadeh (ORCID: https://orcid.org/0000-0003-3593-1852)
- Sven Guenther Meuth (ORCID: https://orcid.org/0000-0003-2571-3501)
- Joachim Havla (ORCID: https://orcid.org/0000-0002-4386-1340)
- Phillip J. Albrecht (ORCID: https://orcid.org/0000-0002-9677-0442)
- Klaudia Lepka
- Laurence Klotz
Institutions
- Witten/Herdecke University (DE)
- University of Southern Denmark (DK)
- University of Münster (DE)
- Humboldt-Universität zu Berlin (DE)
- Düsseldorf University Hospital (DE)
- Kliniken Maria Hilf (DE)
- Slagelse Hospital (DK)
- Heinrich Heine University Düsseldorf (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-15
- DOI
- https://doi.org/10.3389/fimmu.2024.1458458
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.85